• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤坏死因子α、肿瘤坏死因子相关凋亡诱导配体及其相关分子在成釉细胞瘤中的表达

Expression of tumor necrosis factor alpha, TNF-related apoptosis-inducing ligand, and their associated molecules in ameloblastomas.

作者信息

Kumamoto Hiroyuki, Ooya Kiyoshi

机构信息

Division of Oral Pathology, Department of Oral Medicine and Surgery, Tohoku University Graduate School of Dentistry, Sendai 980-8575, Japan.

出版信息

J Oral Pathol Med. 2005 May;34(5):287-94. doi: 10.1111/j.1600-0714.2005.00311.x.

DOI:10.1111/j.1600-0714.2005.00311.x
PMID:15817072
Abstract

BACKGROUND

To clarify the roles of the apoptosis signaling pathway mediated by death receptors in oncogenesis and cytodifferentiation of odontogenic tumors, expression of tumor necrosis factor alpha (TNFalpha), TNF-related apoptosis-inducing ligand (TRAIL), and their associated molecules was analyzed in ameloblastomas as well as in tooth germs.

METHODS

Tissue specimens of 10 tooth germs, 40 benign ameloblastomas, and five malignant ameloblastomas were examined by reverse transcriptase-polymerase chain reaction (RT-PCR) and immunohistochemistry to determine the expression of TNFalpha, TNF receptor I (TNFRI), TRAIL, TRAIL receptor 1 (TRAIL-R1), TRAIL-R2, caspase-8, and nuclear factor-kappaB (NF-kappaB).

RESULTS

Expression of TNFalpha, TNFRI, TRAIL, TRAIL-R1, TRAIL-R2, and NF-kappaB mRNA was detected in most samples of normal and neoplastic odontogenic tissues. Expression of caspase-8 mRNA was identified in six of 33 ameloblastomas, but not in 10 tooth germs or one malignant ameloblastoma. Immunohistochemical reactivity for TNFalpha, TRAIL, their receptors, and NF-kappaB was detected in both normal and neoplastic odontogenic tissues. Epithelial expression of TNFalpha was focal in about 50% of tooth germs and ameloblastomas, and TNFalpha expression in neoplastic cells was significantly higher in follicular ameloblastomas than in plexiform ameloblastomas. TRAIL reactivity was evident in epithelial cells neighboring the basement membrane. Receptors for TNFalpha and TRAIL were diffusely expressed in both normal and neoplastic odontogenic epithelium. Expression of caspase-8 was found in some neoplastic cells in three of 37 ameloblastomas, but not in 10 tooth germs or five malignant ameloblastomas. Nuclear NF-kappaB expression was much lower than cytoplasmic expression in both normal and neoplastic odontogenic epithelium.

CONCLUSION

Expression of TNFalpha, TRAIL, and their receptors in tooth germs and ameloblastomas suggests that these death factors might be involved in cytodifferentiation of odontogenic epithelium and tissue structuring of ameloblastomas. Expression of caspase-8 and NF-kappaB suggests that signaling of TNFalpha and TRAIL minimally affects the biological properties of odontogenic epithelial components.

摘要

背景

为阐明死亡受体介导的凋亡信号通路在牙源性肿瘤发生和细胞分化中的作用,对成釉细胞瘤以及牙胚中肿瘤坏死因子α(TNFα)、肿瘤坏死因子相关凋亡诱导配体(TRAIL)及其相关分子的表达进行了分析。

方法

采用逆转录聚合酶链反应(RT-PCR)和免疫组织化学方法检测10个牙胚、40例良性成釉细胞瘤和5例恶性成釉细胞瘤组织标本中TNFα、肿瘤坏死因子受体I(TNFRI)、TRAIL、TRAIL受体1(TRAIL-R1)、TRAIL-R2、半胱天冬酶-8(caspase-8)和核因子κB(NF-κB)的表达。

结果

在大多数正常和肿瘤性牙源性组织样本中检测到TNFα、TNFRI、TRAIL、TRAIL-R1、TRAIL-R2和NF-κB mRNA的表达。在33例成釉细胞瘤中的6例中检测到caspase-8 mRNA的表达,但在10个牙胚或1例恶性成釉细胞瘤中未检测到。在正常和肿瘤性牙源性组织中均检测到TNFα、TRAIL及其受体和NF-κB的免疫组织化学反应。TNFα的上皮表达在约50%的牙胚和成釉细胞瘤中呈局灶性,滤泡型成釉细胞瘤中肿瘤细胞的TNFα表达明显高于丛状型成釉细胞瘤。TRAIL反应在基底膜附近的上皮细胞中明显。TNFα和TRAIL的受体在正常和肿瘤性牙源性上皮中均呈弥漫性表达。在37例成釉细胞瘤中的3例的一些肿瘤细胞中发现了caspase-8的表达,但在10个牙胚或5例恶性成釉细胞瘤中未发现。在正常和肿瘤性牙源性上皮中,核NF-κB的表达远低于细胞质表达。

结论

TNFα、TRAIL及其受体在牙胚和成釉细胞瘤中的表达表明,这些死亡因子可能参与牙源性上皮的细胞分化和成釉细胞瘤的组织结构形成。caspase-8和NF-κB的表达表明,TNFα和TRAIL的信号传导对牙源性上皮成分的生物学特性影响最小。

相似文献

1
Expression of tumor necrosis factor alpha, TNF-related apoptosis-inducing ligand, and their associated molecules in ameloblastomas.肿瘤坏死因子α、肿瘤坏死因子相关凋亡诱导配体及其相关分子在成釉细胞瘤中的表达
J Oral Pathol Med. 2005 May;34(5):287-94. doi: 10.1111/j.1600-0714.2005.00311.x.
2
Detection of mitochondria-mediated apoptosis signaling molecules in ameloblastomas.成釉细胞瘤中线粒体介导的凋亡信号分子的检测
J Oral Pathol Med. 2005 Oct;34(9):565-72. doi: 10.1111/j.1600-0714.2005.00354.x.
3
Immunohistochemical detection of insulin-like growth factors, platelet-derived growth factor, and their receptors in ameloblastic tumors.免疫组织化学检测成釉细胞瘤中胰岛素样生长因子、血小板衍生生长因子及其受体
J Oral Pathol Med. 2007 Apr;36(4):198-206. doi: 10.1111/j.1600-0714.2007.00516.x.
4
Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling.核因子κB的RelA(p65)和c-Rel亚基在肿瘤坏死因子相关凋亡诱导配体信号传导中的不同作用。
Cancer Res. 2003 Mar 1;63(5):1059-66.
5
Detection of Notch signaling molecules in ameloblastomas.成釉细胞瘤中Notch信号分子的检测
J Oral Pathol Med. 2008 Apr;37(4):228-34. doi: 10.1111/j.1600-0714.2007.00629.x. Epub 2008 Jan 19.
6
Expression of bone morphogenetic proteins and their associated molecules in ameloblastomas and adenomatoid odontogenic tumors.骨形态发生蛋白及其相关分子在成釉细胞瘤和腺样牙源性肿瘤中的表达
Oral Dis. 2006 Mar;12(2):163-70. doi: 10.1111/j.1601-0825.2005.01177.x.
7
Sensitivity of prostate cells to TRAIL-induced apoptosis increases with tumor progression: DR5 and caspase 8 are key players.前列腺细胞对TRAIL诱导的细胞凋亡的敏感性随肿瘤进展而增加:死亡受体5(DR5)和半胱天冬酶8是关键因素。
Prostate. 2006 Jun 15;66(9):987-95. doi: 10.1002/pros.20421.
8
Immunohistochemical detection of beta-catenin and adenomatous polyposis coli in ameloblastomas.成釉细胞瘤中β-连环蛋白和腺瘤性息肉病结肠蛋白的免疫组织化学检测
J Oral Pathol Med. 2005 Aug;34(7):401-6. doi: 10.1111/j.1600-0714.2005.00328.x.
9
Apoptosis-related factors (TRAIL, DR4, DR5, DcR1, DcR2, apoptotic cells) and proliferative activity in ameloblastomas.成釉细胞瘤中的凋亡相关因子(肿瘤坏死因子相关凋亡诱导配体、死亡受体4、死亡受体5、诱捕受体1、诱捕受体2、凋亡细胞)及增殖活性
Anticancer Res. 2009 Apr;29(4):1137-42.
10
Expression of TNF-related apoptosis-inducing ligand (TRAIL) and its receptors in gastric carcinoma and tumor-infiltrating lymphocytes: a possible mechanism of immune evasion of the tumor.肿瘤坏死因子相关凋亡诱导配体(TRAIL)及其受体在胃癌和肿瘤浸润淋巴细胞中的表达:肿瘤免疫逃逸的一种可能机制。
J Cancer Res Clin Oncol. 2002 Feb;128(2):73-9. doi: 10.1007/s004320100292. Epub 2001 Dec 12.

引用本文的文献

1
Downregulated miR-524-5p Participates in the Tumor Microenvironment of Ameloblastoma by Targeting the Interleukin-33 (IL-33)/Suppression of Tumorigenicity 2 (ST2) Axis.下调的 miR-524-5p 通过靶向白细胞介素-33(IL-33)/肿瘤抑制因子 2(ST2)轴参与成釉细胞瘤的肿瘤微环境。
Med Sci Monit. 2020 Jan 28;26:e921863. doi: 10.12659/MSM.921863.
2
The regulation of bone turnover in ameloblastoma using an organotypic in vitro co-culture model.使用器官型体外共培养模型对成釉细胞瘤中骨转换的调节
J Tissue Eng. 2016 Sep 29;7:2041731416669629. doi: 10.1177/2041731416669629. eCollection 2016 Jan-Dec.
3
Molecular and genetic aspects of odontogenic tumors: a review.
牙源性肿瘤的分子与遗传学研究进展:综述
Iran J Basic Med Sci. 2015 Jun;18(6):529-36.
4
Trail overexpression inversely correlates with histological differentiation in intestinal-type sinonasal adenocarcinoma.在肠型鼻窦腺癌中,TRAIL过表达与组织学分化呈负相关。
Int J Surg Oncol. 2013;2013:203873. doi: 10.1155/2013/203873. Epub 2013 Oct 7.
5
Microgenomics of ameloblastoma.成釉细胞瘤的微基因组学。
J Dent Res. 2011 Apr;90(4):463-9. doi: 10.1177/0022034510391791. Epub 2011 Jan 31.